Friday, July 12, 2024

CATEGORY

BeiGene

Lung Cancer Treatment Advanced with European Commission Approval of BeiGene’s Tislelizumab

BeiGene, Ltd., a pioneering global oncology company, announced today that the European Commission (EC) has granted approval for the use of tislelizumab as a...

Latest news